Merit Medical Systems Inc
MMSI
$70.99
Closing
▼-0.73%
1D
▼-6.54%
YTD
Market cap
$4.12B
52 week high
$85.57
52 week low
$62.67
Volume
124,283
Check if the stock is halal
Unlock Industry-grade Shariah Compliance for global stocks. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.
We provide unparalleled value and service.
Screened by AAOIFI Certified Shariah Advisor & Auditor.
Get started from just $3.99/month
Market cap
$4.12B
Analysts' Rating
BUY
Price Target (Mean)
86.25
Total Analysts
8
P/E
43.88
Operating Margin
11.15%
Beta
0.92
Revenue Growth (Annual)
7.09%
52 week high
$85.57
52 week low
$62.67
Div. Yield
%
EPS Annual Growth
25.71
Note on Purification and Zakat
- Purification and Zakat (for long-term investing) calculations are in USD per share and based on AAOIFI methodology. AAOIFI requires purification every financial period (e.g. quarterly).
- If you follow S&P Shariah’s Dividend-only purification, then remove the impure income % from the dividends you receive. No purification required for non-dividend paying stocks, according to S&P Shariah.
- For Zakat, if you did not invest in a company from a long term perspective, then consider the shares as trading goods and give 2.5% of the total value if a year has passed on them.
Company Profile
Merit Medical Systems, Inc. designs, develops, manufactures, markets, and sells medical products for interventional and diagnostic procedures. It operates in two segments: cardiovascular and endoscopy. Its cardiovascular segment consists of four product categories: peripheral intervention, cardiac intervention, custom procedural solutions, and original equipment manufacturer (OEM). It sells a variety of products, including cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease and peripheral vascular disease, as well as, cardiac rhythm management, electrophysiology, critical care, breast cancer localization and guidance, biopsy, and interventional oncology and spine devices. Its endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, and tracheobronchial. It also offers a portfolio of dialysis catheter products and the BioSentry Biopsy Tract Sealant System.
